Lexpos News

/Lexpos News/

Drug Tariff Watch – April 2026

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – April 2026 appeared first on Community Pharmacy England.

By |March 27th, 2026|Lexpos News|Comments Off on Drug Tariff Watch – April 2026

MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited)

MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) Drug alert number: EL(26)A/17 Date issued: 26 March 2026 Sandoz Ltd. have informed the MHRA that the Patient Information Leaflet included in specified batches of Apixaban does not contain up‑to‑date information. DMRC reference number: DMRC-38614094 Marketing Authorisation Holder: Sandoz Limited Medicine Details Product [...]

The post MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited) appeared first on Community Pharmacy England.

By |March 26th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Apixaban 2.5mg and 5mg tablets (Sandoz Limited)

Free supply extended to Ciprofloxacin for meningococcal outbreak

NHS England has issued an operational briefing via its regions to all pharmacies and general practices providing an update on the Meningococcal disease outbreak in Kent and announcing the waiving of NHS prescription charges for prophylactic oral Ciprofloxacin prescriptions issued to patients in relation to the outbreak. Prescribers in general practices have been asked to [...]

The post Free supply extended to Ciprofloxacin for meningococcal outbreak appeared first on Community Pharmacy England.

By |March 26th, 2026|Lexpos News|Comments Off on Free supply extended to Ciprofloxacin for meningococcal outbreak

MHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited)

MHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited) Drug alert number: EL(26)A/16 Date issued: 26 March 2026 Quadrant Pharmaceuticals Limited have informed the MHRA that their parallel imported packs of Vesomni 6 mg/0.4 mg modified release tablets have been printed with the incorrect barcode/GTIN on the carton. DMRC [...]

The post MHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited) appeared first on Community Pharmacy England.

By |March 26th, 2026|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Vesomni 6 mg/0.4 mg modified release tablets (Quadrant Pharmaceuticals Limited)

Racist, hostile, verbal and physical abuse of pharmacy teams now a regular occurrence

Regular occurrences of abuse against community pharmacy teams are making their working life increasingly difficult, and at times dangerous, new research from Community Pharmacy England has demonstrated. A recent survey of more than 3,000 pharmacy premises found that: More than half (55%) of pharmacies had experienced verbal abuse in the preceding six months, with three-quarters [...]

The post Racist, hostile, verbal and physical abuse of pharmacy teams now a regular occurrence appeared first on Community Pharmacy England.

By |March 26th, 2026|Lexpos News|Comments Off on Racist, hostile, verbal and physical abuse of pharmacy teams now a regular occurrence